Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Funds Aren’t Crazy About Mallinckrodt PLC (MNK) Anymore

We can judge whether Mallinckrodt PLC (NYSE:MNK) is a good investment right now by following the lead of some of the best investors in the world and piggybacking their ideas. There’s no better way to get these firms’ immense resources and analytical capabilities working for us than to follow their lead into their best ideas. While not all of these picks will be winners, research shows that these picks historically outperformed the market when we factor in known risk factors.

Is Mallinckrodt PLC (NYSE:MNK) a buy, sell, or hold? The best stock pickers are taking a pessimistic view. The number of long hedge fund positions were trimmed by 3 in recent months. Mallinckrodt PLC (NYSE:MNK) was in 40 hedge funds’ portfolios at the end of the third quarter of 2015. There were 43 hedge funds in our database with Mallinckrodt PLC (NYSE:MNK) positions at the end of the previous quarter. At the end of this article, we will also compare Mallinckrodt PLC (NYSE:MNK) to other stocks, including Melco Crown Entertainment Ltd (ADR) (NASDAQ:MPEL), Alleghany Corporation (NYSE:Y), and Global Payments Inc (NYSE:GPN) to get a better sense of its popularity.

Follow Mallinckrodt Plc (NYSE:MNK)
Trade (NYSE:MNK) Now!

If you’d ask most market participants, hedge funds are assumed to be underperforming, old financial tools of yesteryear. While there are more than 8000 funds trading at the moment, our experts look at the elite of this club, around 700 funds. These investment experts handle the lion’s share of all hedge funds’ total asset base, and by observing their highest performing picks, Insider Monkey has deciphered various investment strategies that have historically outperformed the S&P 500 index. Insider Monkey’s small-cap hedge fund strategy outpaced the S&P 500 index by 12 percentage points per year for a decade in their back tests.

With all of this in mind, we’re going to review the fresh action regarding Mallinckrodt PLC (NYSE:MNK).

What have hedge funds been doing with Mallinckrodt PLC (NYSE:MNK)?

At the end of the third quarter, a total of 40 of the hedge funds tracked by Insider Monkey were long this stock, a decline of 7% from one quarter earlier. With hedge funds’ sentiment swirling, there exists a select group of key hedge fund managers who were upping their stakes substantially (or already accumulated large positions).

According to publicly available hedge fund and institutional investor holdings data compiled by Insider Monkey, John Paulson’s Paulson & Co has the largest position in Mallinckrodt PLC (NYSE:MNK), worth close to $421.6 million, amounting to 2.2% of its total 13F portfolio. On Paulson & Co’s heels is Viking Global, led by Andreas Halvorsen, holding a $250.1 million position; 1% of its 13F portfolio is allocated to the company. Remaining peers that are bullish consist of Phill Gross and Robert Atchinson’s Adage Capital Management, Neal C. Bradsher’s Broadwood Capital, and D E Shaw.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.